Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
2008
Cancer statistics, 2024
2024 Standout
Cancer Statistics, 2021
2021 Standout
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma
2008
Pancreatic cancer
2004 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Pancreatic cancer
2020 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Apoptosis-Inducing Effect of Chemotherapeutic Agents Is Potentiated by Soy Isoflavone Genistein, a Natural Inhibitor of NF-??B in BxPC-3 Pancreatic Cancer Cell Line
2004
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
2009
Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy
2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
The Glasgow Prognostic Score Is a Good Predictor of Treatment Outcome in Patients with Unresectable Pancreatic Cancer
2010
Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine
2009 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation
2008
Multi-targeted therapy of cancer by genistein
2008 Standout
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
2016
Camptothecin and Podophyllotoxin Derivatives
2006
Cisplatin: The first metal based anticancer drug
2019 Standout
Pancreatic Cancer
2010 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
Natural products to drugs: natural product derived compounds in clinical trials
2005
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Natural products in drug discovery
2008 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: A Children's Oncology Group study
2007
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Pancreatic cancer
2011 Standout
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
2009
Medical Advances and Racial/Ethnic Disparities in Cancer Survival
2009
Marine natural products
2015 Standout
Social Conditions as Fundamental Causes of Health Inequalities: Theory, Evidence, and Policy Implications
2010 Standout
Inactivation of Nuclear Factor κB by Soy Isoflavone Genistein Contributes to Increased Apoptosis Induced by Chemotherapeutic Agents in Human Cancer Cells
2005
Natural product and natural product derived drugs in clinical trials
2014 Standout
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Kinase Inhibitors of Marine Origin
2013
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
2007
Enzymatic Generation of the Chromopyrrolic Acid Scaffold of Rebeccamycin by the Tandem Action of RebO and RebD
2005
Works of Vikash Jain being referenced
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer
2003
A phase II study of carboplatin and paclitaxel in esophageal cancer
2004
Phase II trial of fenretinide in advanced renal carcinoma
2005
Efficacy and Safety of Reteplase for Central Venous Catheter Occlusion in Patients with Cancer
2004
A Phase II Study of Carboplatin and Paclitaxel in Adenocarcinoma of Unknown Primary
2005
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma
2006
Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer
2003